chrisvoncsefalvay/vaers-outcomes huggingface dataset:
body aches increased; headache worse; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration (reported as injection) in the left arm on 08Jan2021 at a single dose for COVID vaccine due to the patient's age and lives in continued care retirement community. Medical history included ongoing pain and ongoing persistent headaches, both since 2009. Concomitant medication included erenumab aooe (AIMOVIG) from an unspecified date in 2020 (started taking it 3 months ago). The patient reported side effect from the vaccine received on 08Jan2021. She has had body aches and headaches since 2009, so she figured after reading about the side effects, she would probably have worse body and headaches, but the body aches lasted maybe 4-5 days, from the time of vaccination, she has what was called new daily persistent headaches, which was a rare form of headache. They didn't have meds for it, because not many people have it, it was not a money maker to try to find something that works. She figured this would make headache worse and that was what it did, they were normally a level 7 or 8 on an unspecified date, and they increased to a level 9 on Jan2021, and she couldn't find a way to get it back down. The patient called her headache specialist and she thought steroid injections might help but wanted her to talk to someone to let them know the side effect the patient was having, with the headaches. Her body aches never go away, headaches never go away, and the day of the vaccine, she still had them both as normal, but after receiving the vaccine, her body aches increased, they went up a level, they were normally, a level 7 on an unspecified date, and after the vaccine, they went up to an 8.5 on Jan2021. She took Tylenol, regularly, every 4 to 6 hours, and after about 4 days, the body aches were down to the normal ache. But, the headache did not. The headache was starting to get worse. The outcome of the event body aches increased was recovering while the other event was not recovered.  Information on the lot/batch number has been requested.
Patient states within 5 hours after vaccines, high fatigue, sore arm. After 10 hours, sharp shooting pain in right upper to lower arm; difficult to move arm.
This is a spontaneous report received from a contactable consumer, the patient. A 70-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199) via an unspecified route of administration in the right arm on 19Mar2021 at 10:30 (at the age of 70-years-old), as a single dose for COVID-19 immunisation. The patients medical history included rash from flu vaccine several years ago and hay fever. The patient was allergic to various medications (unspecified). Concomitant medications included vitamin B (MANUFACTURER UNKNOWN), vitamin D (MANUFACTURER UNKNOWN) and vitamin C (MANUFACTURER UNKNOWN) for unspecified indication. The patient received these medications within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6200) via an unspecified route of administration at right arm on 26Feb2021 at 11:00 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 21Mar2021, 43 hours after receiving the second dose of vaccine, the patient experienced raised red rash which was spreading on trunk, legs, arms and neck. Therapeutic measure taken as a result of the event red rash included ALLEGRA. The clinical outcome of event red rash spreading on trunk, legs and arms and neck was not resolved at the time of reporting. No follow-up attempts are needed. No further information is expected.
The muscle in both of my arms where the shot was given hurts; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in arm left on 09Aug2021 14:00 (Batch/Lot Number: EW0170) as DOSE 1, SINGLE (at the age of 64-years-old) and dose 2 via an unspecified route of administration, administered in arm right on 30Aug2021 14:00 (Batch/Lot Number: Ew0175) as DOSE 2, SINGLE (at the age of 64-years-old) for COVID-19 immunisation. Medical history was none. The patient's concomitant medications were not reported. The patient was not pregnant. The patient had no other vaccine in four weeks prior to COVI-19 vaccine. The patient had no known allergies. She did not have covid prior vaccination and had not been tested for covid since vaccination. It was reported that the muscle in both of the patient's arms where the shots were given hurts. She mentioned that she can hardly use her left arm. It started the day she got her first shot, it had gotten worse with time. She mentioned that her right arm was not as bad but it still hurts. The event's onset was on 09Aug2021 20:00 with outcome of not recovered, The event was reported to have resulted to disability or permanent damage. The patient did not receive treatment for the event.   Follow-up attempts are completed. No further information is expected.
Fever (high), chills, couldn't walk, couldn't eat, vomiting, nausea. Gave IV fluids, & anti nausea meds, joint pain, double vision throat burning. Pneumonia shot left burning sensation, diarrhea.
Redness on (L) arm, mild redness and swelling at 80 cm.
Information has been received from a physician concerning a 20 year old female who was off schedule not further specified in the GARDASIL series. The patient received her second dose of GARDASIL greater than 6 months ago, and the first dose was given 6 months before the second dose. There was no concomitant medication. The patient had abnormal PAP test. The patient had had an abnormal PAP with CIN 1 and CIN 2 (cervical intraepithelial neoplasia). HPV type 53 was identified as the type in this abnormal PAP. At the report time the outcome was unknown. Follow-up information indicated that no adverse reaction occurred. No further information is available.
During observation after receiving the vaccine, syncope episode.  Fell from sitting position.  Bruise to forehead.  BP 150/80.  Paleness to skin color.  No known allergies.  No meds.  Previous history of fainting. EMS called & responded.
pain numbness from neck down both arms and around chest.  headache nausea, generalized malise with weakness. remained awake entire night   morning blood sugar was 130 and pressure 140/84  normally 95 and 118/74.  These symptoms continue through today though slightly lessened in severity.  Blood pressure and fasting sugars dropping closer to pre-reaction levels.  On tues 8/6 Dr prescribed Medrol dosepak which was started on 8/7.   Tylenol/aspirin for headaches and lorazepam for dizziness numbness anxiety.
Raised red bump at site of injection, and a splotchy, small red spotted rash around injection site and to the side of it.
Tingling in back of arms when running or walking at times, tingling in hands when doing out of the ocean, small feeling of pricking in hands post being in ocean for 24 hours
Information has been received from a medical assistant referring to an adolescent patient of unknown age and gender. Concurrent conditions, medical history and concomitant medications were not reported. On 09-DEC-2015, the patient was vaccinated with second dose of improperly stored VAQTA, lot # L028666; expiry date 04-NOV-2016, (dose, route and frequency unspecified). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
This initial spontaneous non-serious case was received on 26-Oct-2017, from other non-health professional (consumer), concerning a female pregnant patient of unspecified age. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient received influenza vaccine (dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacturer: not reported).
dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced DIZZINESS (dizzy). At the time of the report, DIZZINESS (dizzy) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by reporter. No treatment information was provided by reporter.   This case was linked to MOD-2021-381238 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-Nov-2021: Non-significant Follow-up
Since she got the vaccine she started feel heavy head, headache, body pain, back pain (she said that she was feeling like had COVID, she has COVID (Nov 2020)  before the only thing was that she did not lost the taste and the smell with the vaccine).  Alot of pain  in the eyes, in the head and after a sharp pain in the right side of her head, behind the ear.    Alot of pain in the body in the right side of the body (leg and arm) some times she can move and all this part of the body were numbed, she had high blood presion.  After beeing in the Hospital return to her house in the 05/10/21 and take medicine for the migrane, and the other day the 05/11/2021 she waek up with a  Bell's palsy. (facial paralysis).    She was in Mexico with the doctor and the result are that she hasd 2 brain strokes and clots in her braind.  Lack of concentration and excess of excessive tiredness.
Patient sought medical treatment on Oct 8 for a vesicular rash to right buttocks and sacral area including groin and shaft of penis. Patient stated rash started on the 5th, one day after receiving the flu vaccine in the clinic. Patient diagnosed with herpes zoster (shingles). Acyclovir 800 mg every day, gabapentin 100 mg other.
Shingles, single line under left breast, 2 days later; Painful; Rash; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, 2 days after receiving Shingrix, the patient experienced shingles, pain and rash. On an unknown date, the outcome of the shingles, pain and rash were unknown.   It was unknown if the reporter considered the shingles, pain and rash to be related to Shingrix.     Additional Information: GSK Receipt Date: 30-AUG-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The reporter reported that the patient received Shingrix vaccine. The reporter stated that after 2 days received Shingrix vaccine the patient experienced rash and Shingles appears in a single line under left breast and it was painful. The patient asked she/he wanted to know she had shingles and how long the shingles last. Follow-up would not possible as no contact details were available.
Left foot joint pain (gout) several days after receiving 1st vaccine shot; Left foot joint pain (gout) several days after receiving 1st vaccine shot; This is a spontaneous report from a contactable consumer (patient). A 48-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN 5318), via an unspecified route of administration, administered in Arm Left on 24Feb2021 15:30 (at the age of 48-year-old) as dose 1, single for COVID-19 immunization. The patient medical history was not reported. The patient had no allergies to medications, food, or other products. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced left foot joint pain (gout) several days after receiving 1st vaccine shot. The patient had started to notice the adverse event on left foot on Monday, 01Mar2021. Monday, 01Mar2021 was when he had first noticed the adverse event (joint pain) on his left foot after he had received the 1st dose of Pfizer vaccine on Wednesday, 24Feb2021. The adverse event resulted in Doctor or other healthcare professional office/clinic visit and received treatment. The patient was prescribed Colchicine. The patient underwent lab test an procedure X-ray left foot on an unspecified date. Since the vaccination, the patient had not been tested for COVID-19. Outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Employee received Hep-B #3 6/12/2013, donor returned to center 6/14/2013 and has swelling, warm to touch at injection site of wheal.
SWELLING AND PAIN AT INJECTION SITE EXTENDING INTO FOREARM, SHOULDER AND NECK
5 days later developed rash and still lump at injection site. In day or 2 following injection, arm was sore, some flare up in systemic fibromyalgia pain.
Janssen COVID-19 Vaccine EUA Severe headache, body aches, fatigue for more than 24 hours after vaccine. Feels debilitating. Symptoms barely changed after taking 2 Advil pills.
The patient came to receive a booster COVID vaccine. The appointment scheduler and nurse verbally verified with patient and patient spouse that he received Pfizer for dose number one and two. Both patient and spouse verbally agreed that patient received Pfizer. The nurse verbally verified with the patient and the patient spouse that it had been 6 months or greater since the second COVID vaccine dose. Both patient and spouse agreed that it had been 6 months + since the second dose. Pfizer vaccine given to the patient at the patient's scheduled appointment time, 1544. The nurse went to chart at 1630 into the Database that patient had received his booster of Pfizer, she had seen that Moderna had been given for the patient's first and second COVID vaccine doses. Called wife to verify what COVID vaccine patient had received for his first and second dose. The wife stated Pfizer, when the nurse tells her that the Database list that he received Moderna 5/4/2021 and 6/4/2021 from Pharmacy. The wife stated she will look at his records and get in touch with Nurse. Wife calls to notify the nurse that on their records the patient received Moderna on those dates at that pharmacy.
Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 1/15/2021 and 2/12/2021. Presented to ED after referral from primary care provider on 8/4/2021 for hypoxia. Patient was hospitalized, placed on oxygen supplementation and received dexamethasone, remdesivir, and tocilizumab. Oxygen demand continued to increase so patient was transferred to hospital on 8/8/2021 after chest tube placement. On 8/14/2021, patient required mechanical ventilation for respiratory distress. Patient received multiple rounds of antibiotics. Head CT confirmed an ischemic stroke. Patient continued to decompensate requiring vasopressor support and developed an ileus. After discussion with family, comfort care measures were pursued and patient expired at 1420 on 9/6/2021.
Immediately after vaccine administration, patient reported he felt  faint.  Had flushed cheeks and increased blood pressure. Had patient recline and was monitored for 20 minutes and felt better.
01/16/22 presents to EC ED for "diarrhea". PMHx of "Crohn's disease, chronic anemia, recurrent GI bleed"
Pt received Pfizer x2.  Pt tested COVID + on 9/21/21 and admitted to hospital for COVID on 9/21/2021. Pt receiving remdesivir and dexamethasone.
Experiencing diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Experiencing diarrhea) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced DIARRHOEA (Experiencing diarrhea). At the time of the report, DIARRHOEA (Experiencing diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products use was not provided by the reporter
After pt sat down, she explained that she missed her vaccine, where she goes to school. After giving vaccine, pt slumped [while seated], I caught her with my arm/hand. Called for back up. 911 was called. Pt immediately turned red...woke up and then became very pale. Paramedics arrived and took pt to hosp.
Evening of vaccine, had chills, fever, aches, tiredness. The following day, she still had flu-like symptoms, which were followed by severe chest pain. She then went to the emergency room. They did a cardiac work-up, then sent her home.
PEDVAXHIB was administered after a temperature excursion; This initial spontaneous report as received from a Licensed Practical Nurse concerning a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug allergies/drug reactions and concomitant medications were not reported.       On 01-DEC-2021, the patient was vaccinated with a dose haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (strength, dose, frequency, and route not provided) Lot # T037651 and expiration date: 20-JUL-2023 for prophylaxis.  It was reported that the vaccine was administered after a temperature excursion at 46.9 F for 30 minutes. Additionally, it was stated that the vaccine had previous temperature excursion at 48F for 30 minutes.
covid_test_result=Positive; covid_test_result=Positive; Dose received:3; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202200065177 (Pfizer).  A 24 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 15Dec2021 (Lot number: FF2587) at the age of 24 years as dose 3 (booster), single, intramuscular, administered in arm left, administration date 24Apr2021 (Lot number: EW0171) as dose 2, single and intramuscular, administered in arm left, administration date 04Apr2021 (Lot number: EW0150) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications.The following information was reported: IMMUNISATION (medically significant) with onset 15Dec2021, outcome "unknown", described as "Dose received:3"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 11Jan2022, outcome "unknown" and all described as "covid_test_result=Positive"; OROPHARYNGEAL PAIN (non-serious) with onset 06Jan2022, outcome "recovering", described as "sore throat"; RHINORRHOEA (non-serious) with onset 06Jan2022, outcome "recovering", described as "runny nose"; NASAL CONGESTION (non-serious) with onset 06Jan2022, outcome "recovering", described as "congestions"; HEADACHE (non-serious) with onset 06Jan2022, outcome "recovering", described as "minor headaches". The patient underwent the following laboratory tests and procedures: polymerase chain reaction: (11Jan2022) positive, notes: Nasal Swab. Therapeutic measures were taken as a result of oropharyngeal pain, rhinorrhoea, nasal congestion, headache.  Additional Information: Treatment received for the adverse event are Tylenol. Prior to vaccination, the patient was not diagnosed with COVID-19, Since the vaccination, the patient has been tested for COVID-19.  Follow-Up (17Jan2022): Follow-up attempts are completed. No further information is expected.
After dose 3: bleeding gums started in December and then progressed to mouth ulcers and severe sore throat by early February. Difficulty swallowing and taking medications. Dry nasal passages with daily nose bleeds soon followed.  Was at Urgent Care twice, Acute Care once, doctors office three times.
This spontaneous report as received from a physician refers to an unspecified number of  patients of unknown age and gender. On an unknown date, the patients were vaccinated with improperly stored doses VARIVAX (5 doses) (dose, route, lot# and expiry date were not reported). No adverse effects reported. This is one of two reports received from the same source. Additional information has been requested.; Sender's Comments: US-009507513-1612USA013766:
petechial rash; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: not reported), dose 1 via an unspecified route of administration on 28Apr2021 as a DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced petechial rash on an unspecified date in 2021. The patient said that, was currently working on Covid diagnostics. I received my first Covid vaccine on 28Apr2021. Right after, my arm displayed a severe 'petechial rash', as diagnosed by my PCP, and I was recommended not to take the booster shot. Three months later, my whole family got sick with Covid (all of them symptomatic with fever, vomit and lethargic), probably with delta variant because of the RNA amplification display. And I stayed confined at home with all three of them, taking care of them, for two weeks. And against all odds, I did NOT get the disease. Patient said, I keep testing myself several times a week (qPCR), and I always come back negative. The patient underwent lab tests and procedures which included sars-cov-2 test that was negative on an unspecified date. Outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
EXTREME FATIGUE/EXTREMELY TIRED; SNEEZING; GENERALIZED PAIN; FLU LIKE SYMPTOMS; This spontaneous report received from a patient concerned a 51 year old female. The patient's height, and weight were not reported. The patient's past medical history included kidney transplant. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, and batch number: 1808609 expiry: UNKNOWN) dose was not reported, administered on 24-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 25-MAR-2021, the subject experienced generalized pain. On 25-MAR-2021, the subject experienced flu like symptoms. On 26-MAR-2021, the subject experienced sneezing. On 31-MAR-2021 17:00, the subject experienced extreme fatigue/extremely tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sneezing on 31-MAR-2021, had not recovered from extreme fatigue/extremely tired, and generalized pain, and the outcome of flu like symptoms was not reported. This report was non-serious.
The patient was stuck in his left deltoid but there was no vaccine in the syringe. The patient was counseled to have the vaccine administered because he did not receive the dose. The patient refused to receive the vaccine because
Two weeks after my Pfizer booster shot, I had mild chest pressure for around 3 weeks, discomfort laying down, my heart would race and keep me up all night. It felt better when I was standing up and moving around. I suspect I had a mild case of myocarditis.  It seems to improve each day. I quit drinking coffee to help and inclined my bed.